Lymphoma cancer quality performance indicators (QPIs)
Patients diagnosed from October 2019 to September 2022

About this release

This release by Public Health Scotland (PHS) presents performance against the National Lymphoma Quality Performance Indicators (QPIs) in the Cancer QPIs dashboard held within the Scottish Cancer Registry and Intelligence Service (SCRIS).

Main points

• There were 1,167 people diagnosed with Lymphoma in Scotland from October 2021 to September 2022. This is a slight decrease from October 2020 to September 2021 but an increase on October 2019 to September 2020 (1,170 diagnosed from October 2020 to September 2021 and 1,148 from October 2019 to September 2020).
• The reductions in October 2019 to September 2020 numbers are likely to be due to lockdown and social distancing measures implemented due to the COVID-19 pandemic.

NHS Scotland performance against lymphoma quality performance indicators for Oct 19 to Sep 22. QPI 1: 90% target met in 19/20 and 20/21 but not met in 21/22. QPI 2: 90% target met in 19/20 but not met in 20/21 or 21/22. QPI 3: 95% target met in 19/20 but not met in 20/21 or 21/22. QPI 4(i): 95% target met throughout. QPI 4(ii): QPI not in use in 19/20. 90% target met in 20/21 and 21/22. QPI 5: 90% target not met in 19/20 or 21/22 but met in 20/21. QPI 11: 95% target met in 19/20 but not met in 20/21 or 21/22. QPI 12(i): QPI not in use in 19/20. 80% target not met in 20/21 or 21/22. QPI 12(ii): QPI not in use in 19/20. 80% target not met in 20/21 or 21/22.

Close

Lymphoma QPIs

• At Scotland level for October 2021 to September 2022, the target was met for two of the nine indicators.
• Excellent performance was seen in the QPI 4 Cytogenetic testing.
• There are nationally recognised challenges with regards to sufficient capacity in radiology and this has impacted on performance against a number of the QPIs (QPIs 1, 2, 3 and 12).
• The majority of the QPIs set have been challenging to achieve. NHS Boards continue to review service delivery, particularly for those services where there remains room for further service improvement.  This includes, for example, radiology imaging and reporting.

Background

National cancer quality performance indicators have been developed to support continuous quality improvement in cancer care (CEL 06 2012). NHS Boards are required to report these indicators against a clinically agreed indicator specific target as part of the mandatory national cancer quality programme. They have been developed collaboratively by North Cancer Alliance, South East Scotland Cancer Network, West of Scotland Cancer Network, Healthcare Improvement Scotland and PHS.

Further information

• The Cancer QPIs dashboard is restricted and may be accessed with permission via the User Access System.
• Network reports on lymphoma QPIs: NCA and WoSCAN
• QPI definitions and updates on lymphoma indicators on the Healthcare Improvement website.
• PHS QPI publications on the former ISD Scotland Beta website.

The next release of this publication will be November 2026.